what qualifies for glp 1 Indications GLP-1/GIP RA Summary Sheet and Beyond! What BMI Do You Need

The product reached the market at end-2023, and due to several factors (Novo supply constraints, versions available from compounding pharmacies, and the attractive profile) the product is gaining market share and has now captured more than 50% of total volumes in the US

doi:10.1186/1472-6963-10-159 Sarwer DB, Gasoyan H, Bauerle Bass S, Spitzer JC, Soans R, Rubin DJ

Many patients achieve significant and lasting weight loss when these medications are combined with lifestyle changes

doi: 10.1210/clinem/dgac082 2 TauberMHoybyeC

2021 doi: 10.1172/JCI146353

GLP-1 receptor agonists, such as Wegovy, which contain the active ingredient semaglutide, are a class of medications widely used for obesity and type 2 diabetes